Your institution may have access to this item. Find your institution then sign in to continue.
Title
The Price Is Right?
Abstract
The article discusses transfer pricing for multinational firms. According to a survey conducted by Ernst & Young, U.S. companies consider transfer pricing to emerge as a major tax issue for them. Consultant Richard Cooper observes that pharmaceutical firms and firms with significant intangible assets are among those apt to attract the notice of tax authorities.